Electrophoretic characterization of LNP/AAV‐encapsulated nucleic acids: Strengths and weaknesses
ELECTROPHORESIS · 2023-10 · 44 (19-20) · 1595-1606
DOI: 10.1002/elps.202300127 ↗Kurz gefasst
Fachartikel in der Zeitschrift ELECTROPHORESIS, online erschienen am 25.08.2023. Verfasst von Andrei Hutanu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharma Technical Development, Cell and Gene Therapy Unit, F. Hoffmann-La Roche AG, Basel, Switzerland. Hauptthemen laut MEDLINE: Nucleic Acids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The use of nucleic acids (NAs) has revolutionized medical approaches and ushered in a new era of combating various diseases. Accordingly, there is an increasing demand for accurate identification, localization, quantification, and characterization of NAs encapsulated in nonviral or viral vectors. The vast spectrum of molecular dimensions and intra‐ and intermolecular interactions presents a formidable obstacle for NA analytical development. Typically, the comprehensive analysis of encapsulated NAs, free NAs, and their spatial distribution poses a challenge that is seldom tackled in its complete complexity. The identification of appropriate physicochemical methodologies for large nonencapsulated or encapsulated NAs is particularly intricate and necessitates an evaluation of the analytical outcomes and their appropriateness in addressing critical quality attributes. In this work, we examine the analytics of non‐encapsulated or encapsulated large NAs (>500 nucleotides) utilizing capillary electrophoresis (CE) and liquid chromatography (LC) methodologies such as free zone CE, gel CE, affinity CE, and ion pair high‐performance liquid chromatography (HPLC). These methodologies create a complete picture of the NA's critical quality attributes, including quantity, identity, purity, and content ratio.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharma Technical Development, Cell and Gene Therapy Unit, F. Hoffmann-La Roche AG, Basel, Switzerland.
- Department of Chemistry, University of Basel, Basel, Switzerland.
- Solvias AG, Kaiseraugst, Switzerland.
ORCID-Profile: Andrei Hutanu
Zitieren
APA
Hutanu, A., Ferreiro, M. L., van Haasteren, J., Höcker, O., Montealegre, C., Mäser, M., Keresztfalvi, A., Monti, J., & Schwarz, M. A. (2023). Electrophoretic characterization of LNP/AAV‐encapsulated nucleic acids: Strengths and weaknesses. ELECTROPHORESIS, 44(19-20), 1595-1606. https://doi.org/10.1002/elps.202300127
Vancouver
Hutanu A, Ferreiro ML, van Haasteren J, Höcker O, Montealegre C, Mäser M, et al. Electrophoretic characterization of LNP/AAV‐encapsulated nucleic acids: Strengths and weaknesses. ELECTROPHORESIS. 2023;44(19-20):1595-1606. doi:10.1002/elps.202300127
BibTeX
@article{Hutanu2023,
author = {Hutanu, Andrei and Ferreiro, Miriam López and van Haasteren, Joost and Höcker, Oliver and Montealegre, Cristina and Mäser, Marina and Keresztfalvi, Alex and Monti, Jose and Schwarz, Maria Anna},
title = {Electrophoretic characterization of LNP/AAV‐encapsulated nucleic acids: Strengths and weaknesses},
journal = {ELECTROPHORESIS},
year = {2023},
volume = {44},
number = {19-20},
pages = {1595--1606},
doi = {10.1002/elps.202300127}
}
EUVIMED